Fifth Annual Advances in Hematology and Oncology Fall Symposium

Green Bay , WI US
October 22, 2016

The practice of clinical hematology and oncology has been rapidly changing in recent years. Diseases and conditions that previously were extraordinarily difficult to manage have seen new treatment options emerge that have significantly improved clinical outcomes. The Fifth Annual Advances in Hematology and Oncology Fall Symposium will update participants on metastatic colorectal cancer, chronic lymphocytic leukemia, radiation oncology, advanced renal cell carcinoma, nursing session, multiple myeloma, and nonsmall cell lung cancer.

The program is designed to provide practical information on evidence-based practice guidelines and the availability of cancer clinical trials. It is directed at clinicians involved in the treatment of oncology patients including physicians, physician assistants, pharmacists, nurse practitioners.

ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.5 hours of participation for continuing education for allied health professionals. 

AGENDA

6:45-7:45AM      Breakfast            

7:50-8:00AM      Introduction | John Burfeind, MD

8:00-8:40 AM     Advances in Regional Therapy for Metastatic
                          Colorectal Cancer 
                          Harveshp Mogal, MD

8:40-9:20AM      New Advances In Chronic Lymphocytic
                          Leukemia | William Wierda, MD

9:20-9:40AM      Break   

9:40-10:20AM    Breakout Session

 1. Radiation Oncology:  New Technologies | Meena Bedi, MD
 2. Multidisciplinary Management of Advanced Rena Cell Carcinoma 
     Kathryn Bylow, MD & Peter Langenstroer, MD, MS
 3. Enhancing Safety in an Inpatient Oncology Setting 
     Rebecca Martin, BSN, RN, OCN, BMTCN

10:30-11:10AM  CAR-T Cells and the Management of
                          Multiple Myeloma | Jeff Medin, MD and 
                          Parameswaran Hari, MD

11:10-12:00PM  Lunch   

12:00-12:40PM  The Use of Molecular Targeting in the Treatment Of
                          Nonsmall Cell Lung Cancer | Joan Schiller, MD

12:40-12:45PM  Adjournment | John Burfeind, MD

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Registered Nurses

Learning Objectives

  1. Summarize current evidence-based practice guidelines for topic area presented.
  2. List currently available clinical trials that will benefit patients.
  3. Discuss the most current scientific and clinical research data and apply information to clinical practice. 
Additional information

CME Coordinator Contact Information

Name: 
Dan Bullock and Erica Katuszonek
Phone Number: 
+1 (414) 805-4600
Course summary
Available credit: 
  • 3.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
03/16/2016
Course expires: 
03/21/2017
Event starts: 
10/22/2016 - 7:00am
Event ends: 
10/22/2016 - 1:00pm
Cost:
$0.00
Hyatt on Main, KI Convention Center
333 Main Street
Green Bay , WI 54301
United States

Hyatt on Main and KI Convention Center 
333 Main Street 
Green Bay, WI 54301

A block of rooms have been set-aside for meeting attendees on Friday evening October 21st at the Hyatt on Main (Attached to the KI Center), at a special reate of $142 (single or double occupany). Reservations can be made by phone.

Phone Reservations: (888) 421-1442 Group Name: Medical College of Wisconsin

Complimentary parking is available for overnight Hyatt guests. Event attendees should park in the Washington Commons Main Street Parking Ramp, Attached to the KI Convention Center by a connecting skywalk. 


Guest Speakers

Joan H. Schiller, MD
Deputy Director for Clinical Investigation
Inova Schar Cancer Institute

William G. Wierda, MD, PhD
Professor and Chief, Section of CLL
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center

Speakers

Meena Bedi, MD
Assistant Professor
Department of Radiation Oncology
Medical College of Wisconsin

Kathryn Bylow, MD
Assistant Professor of Medicine
Division of Hematology and Oncology
Department of Medicine
Medical College of Wisconsin

Peter Langenstroer, MD. MS
Professor of Medicine
Department of Urologic Surgery
Medical College of Wisconsin

Rebecca Martin, BSN, RN, OCN, BMTCN
Staff RN/Educator Inpatient BMT & 4NT
Froedtert and the Medical College of Wisconsin

Jeffrey A. Medin, MD, PhD
MACC Fund Professor
Division of Hematology and Oncology
Department of Pediatrics
Medical College of Wisconsin

Parameswaran Hari, MD, MS
Armand Quick Professor of Hematology
Director of Adult Blood and Marrow Transplant Program
Section Head of Hematologic Malignancies and BMT
Professor of Medicine
Division of Hematology and Oncology

Medical College of Wisconsin

Harveshp Mogal, MD
Assistant Professor of Surgery
Division of Surgical Oncology 
Medical College of Wisconsin 

Planning Committee 

John Burfeind, MD, Program Director
Thomas Abshire, MD
Jules Blank, MD 
David Groteluschen, MD
Parameswaran Hari, MD, MS
Mary Horowitz, MD, MS, FACP
Anthony Jaslowski, MD, FACP
Erica Katuszonek
Wendy Peltier, MD
J. Douglas Rizzo, MD, MS
James Thomas, MD, PhD
Monica Williams

All persons in control of content have NO relevant relationships to disclose with the exception of:

Parameswaran Hari, MD, MS, Celgene, Takeda

Jeffrey Medin, PhD, AvroBio, Plexcera Therapeutics, Rapa Therapeutics

William Wierda, MD, PhD, Sanofi, Genetech/Roche, Celgene, Gilead, GSK/Novartis, Merck, AbbVie, Emergent, Karyopharm, Pharmacyclics, Ascerta, Jansen, Juno Therapeutics, KITE Pharma

Joan Schiller, MD, OncoGenex, Astra Zeneca, Halozyne, Genetech, Bristol Myers, Merck, Xcovery

John Burfeind, MD, Medical Logic, Inc.

In accordance with the ACCME® standards for Commercial Support # 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of resolution process and resolved.

Available Credit

  • 3.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.50 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
03/16/2016
Course expires: 
03/21/2017

Price

Cost:
$0.00
Please login or register to take this course.